Richard Doll Seminar: Incorporating biomarkers into breast cancer trials - where are we at?
Professor Judith Bliss, Institute of Cancer Research
Richard Doll Seminars
Tuesday, 29 January 2019, 1pm to 2pm
Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, OX3 7LF
Judith Bliss is Professor of Clinical Trials at The Institute of Cancer Research, London, Director of its Cancer Research UK funded Clinical Trials & Statistics Unit (ICR-CTSU) and an NIHR Senior Investigator.
A trials statistician with over 30 years’ experience, her professional interests are in the design and analysis of cancer clinical trials; driven by a desire that trials are efficient and sufficiently robust to provide the safety and efficacy results required to directly influence routine clinical practice internationally. She has been a long standing member of the UK NCRI Breast CSG and is Chair of the UK Breast Intergroup and of the NCRI Cancer CTU Group.
Focus for contemporary trial activity is on establishing evidence for biologically targeted therapies utilising biologically-defined intermediate endpoints to drive therapeutic choices and predict outcomes. She collaborates with key clinical and scientific opinion leaders and pharmaceutical company partners as required. She is working with NCRAS to overcome the challenges of integrating routinely collected data in ongoing trials.